Avaliação in vitro das características antimicrobianas de sugamadex
In vitro evaluation of antimicrobial features of sugammadex
Volkan Hanci; Ahmet Vural; Sevgi Yilmaz Hanci; Hasan Ali Kiraz; Dilek Ömür; Ahmet Ünver
Resumo
Palavras-chave
Abstract
Keywords
References
Heldmann E, Brown DC, Shofer F. The association of propofol usage with postoperative wound infection rate in clean wounds: a retrospective study. Vet Surg. ;28:259-256.
Henry B, Plante-Jenkins C, Ostrowska K. An outbreak of Serratia marcescens associated with the anesthetic agent propofol. Am J Infect Control. ;29:312-315.
Crowther J, Hrazdil J, Jolly DT, Galbraith JC, Greacen M, Grace M. Growth of microorganisms in propofol, thiopental, and a 1:1 mixture of propofol and thiopental. Anesth Analg. ;82:478-475.
Sosis MB, Braverman B, Villaflor E. Propofol, but not thiopental, supports the growth of andida albicans. Anesth Analg. ;81:132-134.
Keleş GT, Kurutepe S, Tok D, Gazi H, Dinç G. Comparison of antimicrobial effects of dexmedetomidine and etomidate-lipuro with those of propofol and midazolam. Eur J Anaesthesiol. ;23:1040-1037.
Ayoglu H, Kulah C, Turan I. Antimicrobial effects of two anaesthetic agents: dexmedetomidine and midazolam. Anaesth Intensive Care. ;36:684-681.
Graystone S, Wells MF, Farrell DJ. Do intensive care drug infusions support microbial growth?. Anaesth Intensive Care. ;25:640-642.
Hanci V, Cömert F, Ayoglu H, Kulah C, Yurtlu S, Turan IO. Evaluation of the antimicrobial effects of atracurium, rocuronium and mivacurium. Antimicrobial effects of muscle relaxants. Drugs Ther Stud. ;1:e2.
Naguib M. Sugammadex:. another milestone in clinical neuromuscular pharmacology. Anesth Analg. ;104:575-581.
Brull SJ, Naguib M. Selective reversal of muscle relaxation in general anesthesia: focus on sugammadex. Drug Des Dev Ther. ;3:129-119.
Rex C, Bergner UA, Pühringer FK. Sugammadex: a selective relaxant-binding agent providing rapid reversal. Curr Opin Anaesthesiol. ;23:465-461.
Joo JS, Park KC, Song JY. Thin-layer liquid culture technique for the growth of Helicobacter pylori. Helicobacter. ;15:302-295.
Jean-Baptiste E, Blanchemain N, Martel B, Neu C, Hildebrand HF, Haulon S. Safety, healing, and efficacy of vascular prostheses coated with hydroxypropyl-b-cyclodextrin polymer: experimental in vitro and animal studies. Eur J Vasc Endovasc Surg. ;43:188-197.
Performance standards for antimicrobial susceptibility testing. Document M100-S15.. .
Langevin PB, Gravenstein N, Doyle TJ. Growth of Staphylococcus aureus in Diprivan and Intralipid: implications on the pathogenesis of infections. Anesthesiology. ;91:1394-1400.
Durak P, Karabiber N, Ayoglu H, Yilmaz TH, Erdemli Ö. Investigation on antibacterial activities of atracurium, lidocaine, propofol, thiopentone, and midazolam. Acta Anaesth Ital. ;52:39-43.
Arduino MJ, Bland LA, McAllister SK. Microbial growth and endotoxin production in the intravenous anesthetic propofol. Infect Control Hosp Epidemiol. ;12:535-539.
Sosis MB, Braverman B. Growth of Staphyloccoccus aureus in four intravenous anaesthetics. Anesth Analg. ;77:766-778.
Bar R. A new cyclodextrin-agar medium for surface cultivation of microbes on lipophilic substrates. Appl Microbiol Biotechnol. ;32:472-470.
Douraghi M, Kashani SS, Zeraati H, Esmaili M, Oghalaie A, Mohammadi M. Comparative evaluation of three supplements for Helicobacter pylori growth in liquid culture. Curr Microbiol. ;60:262-254.
Marchini A, d'Apolito M, Massari P, Atzeni M, Copass M, Olivieri R. Cyclodextrins for growth of Helicobacter pylori and production of vacuolating cytotoxin. Arch Microbiol. ;164:293-290.
Olivieri R, Bugnoli M, Armellini D. Growth of Helicobacter pylori in media containing cyclodextrins. J Clin Microbiol. ;31:160-162.
Ohtsuka M, Kikuchi K, Shundo K. Improved selective isolation of Bordetella pertussis by use of modified cyclodextrin solid medium. J Clin Microbiol. ;47:4167-4164.
Letowska I, Chodorowska M, Kaczurba E, Kuklinska D, Tyski S. Bacterial growth and virulence factors production by different Bordetella pertussis strains. Acta Microbiol Pol. ;46:55-45.
Imaizumi A, Suzuki Y, Ono S, Sato H, Sato Y. Heptakis(2,6-O-dimethyl)beta-cyclodextrin: a novel growth stimulant for Bordetella pertussis phase I. J Clin Microbiol. ;17:786-781.
Suzuki Y, Imaizumi A, Ginnaga A, Sato H, Sato Y. Effect of heptakis (2,6-0-dimethyl)beta-cyclodextrin on cell growth and the production of pertussis toxin and filamentous hemagglutinin in Bordetella pertussis. Dev Biol Stand. ;61:92-89.
Zhang HM, Li Z, Uematsu K, Kobayashi T, Horikoshi K. Antibacterial activity of cyclodextrins against Bacillus strains. Arch Microbiol. ;190:605-609.
Yamamura H, Suzuki K, Uchibori K. Mimicking an antimicrobial peptide polymyxin B by use of cyclodextrin. Chem Commun (Camb). ;48:892-894.
Gudmundsson A, Erlendsdottir H, Gottfredsson M. Impact of pH and cationic supplementation on in vitro postantibiotic effect. Antimicrob Agent Chemother. ;35:2617-2624.
Clinton LW, warriner CB, McCormack JP, Alison MC. Reconstituted thiopentone retains its alkalinity without bacterial contamination for up to four weeks. Can J Anaesth. ;39:504-508.
Farrington M, McGinnes J, Matthews I, Park GR. Do infusions of midazolam and propofol pose an infection risk to critically ill patients?. Br J Anaesth. ;72:415-417.